Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction?
- 12 April 1986
- Vol. 292 (6526) , 973-978
- https://doi.org/10.1136/bmj.292.6526.973
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- Tissue Plasminogen Activator (t-PA)New England Journal of Medicine, 1985
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.Circulation, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1981